Trial intelligence / Profile preview

Mitoxantrone Hydrochloride Injection for Tracing vs Carbon Nanoparticles for Lymphatic Mapping in Gastric Cancer Surgery

CTR20231096Phase 3Completed

Sponsor
Shenyang Pharmaceutical University
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mitoxantrone hydrochloride in gastric adenocarcinoma, sponsored by Shenyang Pharmaceutical University. Started Apr 2023; status: completed.

02

Drugs

mitoxantrone hydrochloride
03

Conditions

gastric adenocarcinoma

Beyond the preview

Go deeper on CTR20231096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20231096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call